Chris: I think it is noteworthy to ask ourselves WHY the RP orphan news and Lympro Launch didn't move our stock price? One of the purposes of the mb is to help each other better understand the dynamics of the stock.

Obviously our MANF/Parkinsons indication has the potential for being huge....but not right now. Same with the rest of our pipeline. We need to understand what the market cares about now. The market's eyes are NOT focused on how high and accurate the Lympro numbers are, they are focused on how many pharmas are signing up now that we've launched!!

That's the most pertinent issue for our near term stock price.